David Colleran - EVP, General Counsel, Corp Sec at Anika Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, General Counsel, Corp Sec
Stock Symbol
ANIK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Colleran since 4/23/2024

Holdings reported by David Colleran for Anika Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 48K $763K $15.91 Mar 17, 2025 Direct
Restricted Stock Unit 19.3K $499K $25.79 Mar 15, 2024 Direct Common Stock
Restricted Stock Unit 12.9K $205K $15.91 Mar 17, 2025 Direct Common Stock
Stock Option (Right to Buy) 46.9K Mar 15, 2024 Direct Common Stock

Transactions reported by David Colleran for Anika Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.